<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC137069/" ref="ordinalpos=3033&amp;ncbi_uid=330697&amp;link_uid=PMC137069" image-link="/pmc/articles/PMC137069/figure/F1/" class="imagepopup">Figure 1.  From: The therapeutic potential of modulators of the Hedgehog-Gli <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">The Hh-signaling pathway. <b>(a)</b> A diagram of the Hh-signaling pathway, showing the site of action of the agonists (green) and antagonists (red) discussed in the text, as well as many additional factors that affect the pathway. Abbreviations: CK1, Casein kinase 1; Cos2, Costal2 ; Dyrk1, dual-specificity Yak1-related kinase 1; GSK3, Glycogen synthase kinase 3; Fu, Fused; Gas1, growth arrest specific 1; Hh, Hedgehog; Hip, Hedgehog-interacting protein 1; Rab23, a Rab-family Ras-like GTPase associated with vesicle traffic; Ptc, Patched1; PKA, Protein kinase A; Smo, Smoothened; SuFu, Suppressor of Fused. <b>(b)</b> A schematic generalized view of the regulation of Gli activator (Gli-act) and Gli repressor (Gli-rep) forms by Hh signaling. See [2-4] for further details.</div></div>